MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202647094201 A) filed by Regeneron Pharmaceuticals, Inc. on August 04, 2026, for Viral Particles Retargeted To Nervous System Tissues.
Inventors include Alessandri-Haber, Nicole M.; Buxbaum, Adina; Desclaux, Mathieu; and Moller-Tank, Sven.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: Provided herein are compositions and methods for retargeting viral particles, e.g., adeno-associated virus (AAV) particles, to p75NTR-expressing cells using p75NTR- targeting ligands. AAV adapted accordingly may be a viable gene therapy platform to target nervous system cells (e.g., dorsal root ganglia, trigeminal ganglia, etc.) for the treatment or prevention of pain, itch, or a neurological disease or disorder in a subject in need thereof.
Disclaimer: Curated by HT Syndication.
